RegCell Secures $44 Million Series A Financing to Advance Treg Cell Therapies for Autoimmune Diseases

  FTI portfolio company, RegCell (Headquarters: Emeryville, CA; CEO: Michael McCullar), a biote...

Neusignal Therapeutics Selected for Forbes Asia 100 to Watch 2026

  Neusignal Therapeutics, a Tohoku University startup developing therapeutics for Alzheimer’s d...

Neusignal Therapeutics Completes Series B Financing to Advance Alzheimer’s Disease Program NTX-083

Neusignal Therapeutics, a clinical stage neuroscience biotechnology company developing therapeutics...

Sonire Therapeutics Initiates First U.S. Clinical Trial of Ultrasound-Guided HIFU Therapy in Pancreatic Cancer

  Sonire Therapeutics, a U.S. based clinical stage medical device company developing high inten...

NovAccel Secures Financing to Accelerate Medical Radioisotope Production for Next-Generation Cancer Therapy

  NovAccel, a Japan based company developing the compact superconducting accelerator “RiSA” for...

FTI Invests in Qoly Corporation to Advance Microsurgery Robotics

Qoly Corporation, a medtech company developing robotic technology to support microsurgery, has comp...

AIRNA Doses First Patient in Global Phase 1 Study of RNA Editing Candidate AIR-001 for AATD

  AIRNA (Headquarters: Cambridge, USA), a biotech startup focused on RNA editing therapeutics, ...

STORM Therapeutics Secures $56 Million Series C Financing and Doses First Patient in Phase 2 Sarcoma Trial of STC-15

  STORM Therapeutics, a clinical stage biotechnology company targeting RNA modifications to dev...

Sonire Therapeutics Closes $18 Million Series A to Advance HIFU Therapy for Pancreatic Cancer

  Sonire Therapeutics, a U.S. based clinical stage medical device company developing high inten...

Neusignal Therapeutics completed NTX-083 Phase 1 trial

  Neusignal Therapeutics , a clinical stage neuroscience biotechnology company , announced posi...

Fast Track Initiative Closes approximately 130M USD Fund IV to Advance Healthcare Innovation

  Tokyo, Japan – Fast Track Initiative, Inc. (FTI) today announced the successful closing of Fa...

Neusignal Therapeutics Completes First-in-Human Study of NTX-083 in Healthy Volunteers

  Neusignal Therapeutics (CEO: Yoshifumi Yoshida; Headquarters: Tokyo, Japan; hereinafter refer...

Astellas Exercises Option to License Small Molecules Discovered Through Joint Research on Novel target with Alivexis

  Alivexis, Inc. (CEO: Roy S. Kimura, COO: Kazuki Ohno; Headquarters: Tokyo, Japan; formerly kn...

SONIRE Receives FDA IDE Approval for Ultrasound-Guided HIFU Device in Unresectable Pancreatic Cancer

08.19.2025 - SONIRE Therapeutics (Headquarters: Tokyo, Japan; President and CEO: Tohru Satoh) receiv...

FTI Makes Follow-On Investment in Global Vascular’s Series B to Advance First-in-Human Trials of BioStealth™ Stent

June 30, 2025 — Fast Track Initiative, Inc. (FTI) has completed a follow-on investment in Global Vas...

Japanese Prime Minister Shigeru Ishiba Meets Select Biopharma Leaders

June 26, 2025 – Japanese Prime Minister Shigeru Ishiba convened a high-level public-private council ...

AIRNA Raises USD 155 Million in Oversubscribed Series B Financing to Advance RNA Editing Therapies

 AIRNA (President and CEO: Kris Elverum; Headquarters: Cambridge, USA), a biotech startup focus...

FTI Co-Leads USD 45.8 million Investment in RegCell to Accelerate Development of Treg therapy for Autoimmune Diseases

  Fast Track Initiative (FTI) has co-led a USD 45.8 million funding round for RegCell, Inc. (He...

Alivexis Secures 800M JPY in Series D Funding To Propel Drug Discovery Innovations

Fast Track Initiative, Inc. (FTI) announces its participation in the JPY 800 million first closing o...

SONIRE Therapeutics Receives FDA Breakthrough Device Designation for HIFU Pancreatic Cancer Treatment

SONIRE Therapeutics (Headquarters: Tokyo, Japan; President and CEO: Tohru Satoh; hereinafter referre...

AIRNA Raised Oversubscribed Financing to Advance RNA Editing Therapeutics

Fast Track Initiative (hereinafter referred to as ‘FTI’) has made an additional investment in AIRNA,...

Alivexis and Melodia Therapeutics Join Forces to Advance Innovative Therapies

Alivexis, an FTI-backed drug discovery company with operations in Japan and the United States, has e...

Medii Raises Series A Funding to Enhance "E-Consult," An Exclusive Online Consultation Service for Physicians

Early diagnosis and optimizing treatment for rare diseases and intractable illnesses represent signi...

Fast Track Initiative (FTI) invests in Shinobi Therapeutics, a U.S. and Japan-based company developing hypoimmune iPS cell therapy

Tokyo, Japan and Cambridge, MA, USA, December 12, 2023 - Fast Track Initiative (FTI) is excited to a...

Global Vascular Secures Series A Funding to Advance Innovative Nanotechnology for Peripheral Artery Disease Treatment

Global Vascular (Headquarters: Tokyo, Japan; CEO: Dr. Kenta Bito) has successfully completed a Serie...